Are we ready for ROP telemedicine?

Article

Doctors place focus on delivery of care

Has the time come for widespread adoption of telemedicine screening for retinopathy of prematurity (ROP)?

Dr William Good, suggests that many of the supposed advantages of ROP telemedicine are misleading, but that it could eventually have a useful role.

Communication is awkward, since parents, neonatologists and nurses have no idea what the doctor has seen. Following up on patients requires remembering retinal appearance and recognizing disease progression and if a second opinion is needed or disease is severe, a local expert must be found immediately or arrangements made to transfer the baby elsewhere. The expert who examines the baby must rely on the original sketches and perhaps a description given by phone before transferring the baby back to the ophthalmologist's care or performing laser treatment.

In the second strategy, the examiner takes a detailed look at wide-angle retinal images that can be manipulated to emphasize or highlight certain features. To make clinical decisions, the ophthalmologist measures and compares directly on the images to identify plus disease or zone 1 disease. Documentation is performed by placing the images in the medical record, and communication is easy because everyone can see these images. During follow-up, old and new images can be compared side-by-side. Second opinions can be obtained immediately through secure access to experts throughout the world who can view the series of images.

While acknowledging the important role of ophthalmoscopy in the first scenario, Dr Chiang commented that it was a legitimate question to ask who would choose this technique over the second strategy if both were developed at the same time.

"Indirect ophthalmoscopy is time-intensive and logistically difficult and huge amounts of travel time and coordination time are required," Dr Chiang said.

"It's often subjective and qualitative, and these hand-drawn sketches are a very imprecise way to document findings," he said. "There is enormous medico-legal liability, possibly the biggest in all of ophthalmology, and there are major problems involving ophthalmologist access."

Telemedicine programmes for ROP have been operational since the early 2000s at several major medical centres.

There have been no known cases of treatment-requiring ROP that were missed by telemedicine in these programmes, he continued and predicted that telemedicine images eventually will be integrated into electronic medical records systems and computer-based diagnostic algorithms for identifying plus disease. He cited research studies that demonstrated extremely high accuracy of telemedicine for ROP diagnosis, including cases where it may have been better than indirect ophthalmoscopy exam.

"All of us want to improve the delivery of care and this is a situation where technologies can be applied to … make things [continuously] better," he concluded.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Quan Dong Nguyen, MD, MSc, of the Byers Eye Institute at Stanford University School of Medicine, discusses his presentation on Stargardt disease at the American Academy of Ophthalmology meeting
© 2025 MJH Life Sciences

All rights reserved.